SCHEMBL21099247

SCHEMBL21099247

CN/N=C1\CCCc2cc(OCCOCCOCCOCCOCCC(=O)ON3C(=O)CCC3=O)ccc21

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
GAA P10253 1/20 0.39
KDM4E B2RXH2 2/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 3/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 2/20 0.36
MAOB P27338 3/20 0.36
MAOA P21397 2/20 0.36
MEN1 O00255 1/20 0.35
S1PR1 P21453 1/20 0.35
HRH3 Q9Y5N1 2/20 0.34
PPARG P37231 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
AOC3 Q16853 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21052047 0.88 SMN1; SMN2 (0.43) SMN1; SMN2GAAPOLBMAPTHTT
SCHEMBL22802061 0.88 SMN1; SMN2 (0.43) SMN1; SMN2GAAPOLBMAPTHTT
SCHEMBL21098696 0.87 SMN1; SMN2 (0.43) SMN1; SMN2GAAPOLBMAPTHTT
SCHEMBL21098680 0.87 SMN1; SMN2 (0.43) SMN1; SMN2GAAPOLBMAPTHTT
SCHEMBL30231974 0.79 SMN1; SMN2 (0.42) SMN1; SMN2GAAKDM4EPOLBMAPT
SCHEMBL21098749 0.79 SMN1; SMN2 (0.42) SMN1; SMN2GAAKDM4EPOLBMAPT
SCHEMBL21052174 0.79 SMN1; SMN2 (0.42) SMN1; SMN2GAAKDM4EPOLBMAPT
SCHEMBL21098752 0.77 SMN1; SMN2 (0.40) SMN1; SMN2GAAPOLBMAPTHTT
SCHEMBL17732013 0.73 TSHR (0.42) SMN1; SMN2KDM4EMAPTKMT2AMAOB
SCHEMBL22802055 0.72 MAPT (0.45) SMN1; SMN2GAAKDM4EPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019109188-A1 ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2019-06-13 WO disclosed